Heves megyei aprónyomtatványok 14/A

A Synthetic Antihemorrhagic with a Distinctive Mode of Action

Etamsylate

Acting on primary hemostasis (parietal time) as evidenced by a reduction of bleeding time and volume of blood loss.

No influence on coagulation factors

(coagulation time remains unchanged). DICYNONE is ideal for the treatment of capillary bleedings with a wide margin of safety.

Efficacy proved in more than 200 publications. Presentations:

Ampoules of 2 ml (250 mg) for I.V. or I.M. injections and for topical applications.

Tablets (250 mg) for oral administration.

AA OM Laboratories Ltd. Y \ Geneva (Switzerland)